Diagnos Inc., a Canadian corporation specializing in early detection of critical health issues through its AI-based FLAIRE platform, has engaged Outside The Box Capital Inc. (OTB) for marketing and promotional services. The agreement, effective from January 13, 2025, to April 13, 2025, compensates OTB with CA$50,000, paid in advance. OTB, headquartered in Oakville, Ontario, will utilize digital marketing strategies, including social media, to enhance Diagnos' visibility. The agreement can be terminated by mutual consent and is subject to TSX Venture Exchange approval. OTB and its principals currently hold no interest in Diagnos securities.
Diagnos' FLAIRE platform supports applications like CARA (Computer Assisted Retina Analysis), which enhances retinal images for efficient patient screening. The company emphasizes that forward-looking statements in the release are subject to change and disclaims any obligation to update them. Additional information about Diagnos is available on their website and SEDAR.
Key takeaways:
DIAGNOS Inc. has engaged Outside The Box Capital Inc. to provide marketing and promotional services.
The agreement with OTB is for a period from January 13, 2025, to April 13, 2025, with a compensation of CA$50,000.
OTB will use digital marketing strategies to increase awareness of DIAGNOS, acting at arm's length and with no interest in the corporation's securities.
DIAGNOS specializes in early detection of health issues using its AI-based FLAIRE platform, particularly through its CARA application for retinal image analysis.
